House Speaker questions the inclusion of Medicare and Social Security proposals, suspecting an attempt to disrupt debt ceiling negotiations From the p...
Fed’s Powell Faces Mounting Pressure to Make a Decision on Interest Rates
The upcoming policy meeting of the Federal Reserve has put its Chair, Jerome Powell, in the spotlight as various stakeholders eagerly await a resoluti...
What to know about the Trump-era rollback of bank rules, Silicon Valley Bank’s demise and the current crisis
Experts admitted, told ABC News regulators missed “red flags” before the collapse. NO SHIT! RIGHT? Industry experts are concerned that the...
Stocks That Could Breakout in the Near Term: Ring Energy, Gray Television, and PacWest Bancorp
In this report, we will take a look at three stocks that could potentially breakout and provide significant returns for investors. These stocks are Ri...
Interesting IPO to List on NASDAQ Tomorrow 4-28-2023
As soon as the ticker hits the NASDAQ we will issue this report tomorrow. Anticipating 10-11AM EST this will be issued via Text Message and Email. The...
Bed Bath & Beyond Bankruptcy: What Will Happen to BBBY Shareholders
Bed Bath & Beyond (BBBY) recently issued a warning that it may file for bankruptcy following poor sales performance. The company is considering va...
TRILLIUM CAPITAL ISSSUES PROPOSAL TO ACQUIRE GETTY IMAGES FOR $10 PER SHARE
Trillium Capital has announced an all-cash bid to purchase the remaining shares it doesn’t already own in Getty Images Holdings Inc (NASDAQ: GET...
Special Dividend Just Announced: Flexible Solutions International, Inc. (NYSE American: FSI)
Hello everyone, Let’s look at the average PE for this sector. The Chemicals industry is up 1.4% in the last week, with Linde up 1.8%. In contras...
New to the NASDAQ, Clean Energy, Proprietary Technology Acquired from General Electric
Hello everyone and welcome to all our new members, I hope this correspondence finds you all well. The markets have been crazy this past year but we be...
Three Very Promising Biotech Stocks to Watch in 2023
In 2022, the biotech industry faced a challenging year due to profit-taking, clinical setbacks, stricter FDA regulations, geopolitical unrest, rising ...
